218 related articles for article (PubMed ID: 27912843)
21. ATP citrate lyase is increased in human breast cancer, depletion of which promotes apoptosis.
Wang D; Yin L; Wei J; Yang Z; Jiang G
Tumour Biol; 2017 Apr; 39(4):1010428317698338. PubMed ID: 28443474
[TBL] [Abstract][Full Text] [Related]
22. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle.
Verschueren KHG; Blanchet C; Felix J; Dansercoer A; De Vos D; Bloch Y; Van Beeumen J; Svergun D; Gutsche I; Savvides SN; Verstraete K
Nature; 2019 Apr; 568(7753):571-575. PubMed ID: 30944476
[TBL] [Abstract][Full Text] [Related]
23. Hydroxycitrate causes altered pyruvate metabolism by tumorigenic cells.
Board M; Newsholme E
Biochem Mol Biol Int; 1996 Nov; 40(5):1047-56. PubMed ID: 8955895
[TBL] [Abstract][Full Text] [Related]
24. Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.
Beckner ME; Fellows-Mayle W; Zhang Z; Agostino NR; Kant JA; Day BW; Pollack IF
Int J Cancer; 2010 May; 126(10):2282-95. PubMed ID: 19795461
[TBL] [Abstract][Full Text] [Related]
25. Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.
Ren JG; Seth P; Ye H; Guo K; Hanai JI; Husain Z; Sukhatme VP
Sci Rep; 2017 Jul; 7(1):4537. PubMed ID: 28674429
[TBL] [Abstract][Full Text] [Related]
26. Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage.
Lai L; Reineke E; Hamilton DJ; Cooke JP
Circulation; 2019 Jan; 139(1):119-133. PubMed ID: 30586707
[TBL] [Abstract][Full Text] [Related]
27. Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-Talk.
Greenwood DL; Ramsey HE; Nguyen PTT; Patterson AR; Voss K; Bader JE; Sugiura A; Bacigalupa ZA; Schaefer S; Ye X; Dahunsi DO; Madden MZ; Wellen KE; Savona MR; Ferrell PB; Rathmell JC
Immunohorizons; 2022 Dec; 6(12):837-850. PubMed ID: 36547387
[TBL] [Abstract][Full Text] [Related]
28. Prognostic impact of the combination of glucose transporter 1 and ATP citrate lyase in node-negative patients with non-small lung cancer.
Osugi J; Yamaura T; Muto S; Okabe N; Matsumura Y; Hoshino M; Higuchi M; Suzuki H; Gotoh M
Lung Cancer; 2015 Jun; 88(3):310-8. PubMed ID: 25837797
[TBL] [Abstract][Full Text] [Related]
29. Autotrophic CO2 fixation via the reductive tricarboxylic acid cycle in different lineages within the phylum Aquificae: evidence for two ways of citrate cleavage.
Hügler M; Huber H; Molyneaux SJ; Vetriani C; Sievert SM
Environ Microbiol; 2007 Jan; 9(1):81-92. PubMed ID: 17227414
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of ATP citrate lyase by Cucurbitacin B: A bioactive compound from cucumber, inhibits prostate cancer growth.
Gao Y; Islam MS; Tian J; Lui VW; Xiao D
Cancer Lett; 2014 Jul; 349(1):15-25. PubMed ID: 24690568
[TBL] [Abstract][Full Text] [Related]
31. ATP-citrate lyase: genetics, molecular biology and therapeutic target for dyslipidemia.
Burke AC; Huff MW
Curr Opin Lipidol; 2017 Apr; 28(2):193-200. PubMed ID: 28059952
[TBL] [Abstract][Full Text] [Related]
32. The dual role of citrate in cancer.
Icard P; Simula L; Zahn G; Alifano M; Mycielska ME
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188987. PubMed ID: 37717858
[TBL] [Abstract][Full Text] [Related]
33. ATP-citrate lyase: a mini-review.
Chypre M; Zaidi N; Smans K
Biochem Biophys Res Commun; 2012 May; 422(1):1-4. PubMed ID: 22575446
[TBL] [Abstract][Full Text] [Related]
34. New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.
Santarsiero A; Leccese P; Convertini P; Padula A; Abriola P; D'Angelo S; Bisaccia F; Infantino V
Mediators Inflamm; 2018; 2018():1419352. PubMed ID: 30050389
[TBL] [Abstract][Full Text] [Related]
35. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.
Hochrein SM; Wu H; Eckstein M; Arrigoni L; Herman JS; Schumacher F; Gerecke C; Rosenfeldt M; Grün D; Kleuser B; Gasteiger G; Kastenmüller W; Ghesquière B; Van den Bossche J; Abel ED; Vaeth M
Cell Metab; 2022 Apr; 34(4):516-532.e11. PubMed ID: 35316657
[TBL] [Abstract][Full Text] [Related]
36. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?
Icard P; Simula L; Wu Z; Berzan D; Sogni P; Dohan A; Dautry R; Coquerel A; Lincet H; Loi M; Fuks D
Drug Resist Updat; 2021 Dec; 59():100790. PubMed ID: 34924279
[TBL] [Abstract][Full Text] [Related]
37. Understanding the central role of citrate in the metabolism of cancer cells.
Icard P; Poulain L; Lincet H
Biochim Biophys Acta; 2012 Jan; 1825(1):111-6. PubMed ID: 22101401
[TBL] [Abstract][Full Text] [Related]
38. ACLY and ACC1 Regulate Hypoxia-Induced Apoptosis by Modulating ETV4 via α-ketoglutarate.
Keenan MM; Liu B; Tang X; Wu J; Cyr D; Stevens RD; Ilkayeva O; Huang Z; Tollini LA; Murphy SK; Lucas J; Muoio DM; Kim SY; Chi JT
PLoS Genet; 2015 Oct; 11(10):e1005599. PubMed ID: 26452058
[TBL] [Abstract][Full Text] [Related]
39. Enhanced lipid accumulation in the yeast Yarrowia lipolytica by over-expression of ATP:citrate lyase from Mus musculus.
Zhang H; Zhang L; Chen H; Chen YQ; Chen W; Song Y; Ratledge C
J Biotechnol; 2014 Dec; 192 Pt A():78-84. PubMed ID: 25450640
[TBL] [Abstract][Full Text] [Related]
40. ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch.
Zhao S; Torres A; Henry RA; Trefely S; Wallace M; Lee JV; Carrer A; Sengupta A; Campbell SL; Kuo YM; Frey AJ; Meurs N; Viola JM; Blair IA; Weljie AM; Metallo CM; Snyder NW; Andrews AJ; Wellen KE
Cell Rep; 2016 Oct; 17(4):1037-1052. PubMed ID: 27760311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]